Evaluation of an E1E4-Deleted adenovirus expressing the herpes simplex thymidine kinase suicide gene in cancer gene therapy

Human Gene Therapy

Volumn 10, Issue 3, 1999, Pages 463-475

  Lanuti, Michael ^a   Gao, Guang Ping ^a   Force, Seth D ^a   Chang, Michael Y ^a   El Kouri, Claude ^a   Amin, Kunjlata M ^a   Hughes, Joseph V ^a   Wilson, James M ^a   Kaiser, Larry R ^a   Albelda, Steven M ^a,b  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b 809 Maloney Building/HUP ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; THYMIDINE KINASE; VIRUS VECTOR; ANTIVIRUS AGENT;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER; CONTROLLED STUDY; FEMALE; GENE THERAPY; HERPES SIMPLEX VIRUS; IMMUNOBLOTTING; INTRAPERITONEAL DRUG ADMINISTRATION; MESOTHELIOMA; MOUSE; NONHUMAN; PROMOTER REGION; RAT; ROUS SARCOMA ONCOVIRUS; SCID MOUSE; SUICIDE GENE; TUMOR MODEL; VIRUS GENE; VIRUS MUTANT; ANIMAL; BAGG ALBINO MOUSE; CELL SURVIVAL; COMPARATIVE STUDY; ENZYMOLOGY; EXPERIMENTAL MELANOMA; GENE VECTOR; GENETICS; HERPES SIMPLEX; HUMAN; MOUSE MUTANT; TIME;

ADENOVIRIDAE; ANIMALIA; HERPES; HUMAN HERPESVIRUS 1; ONCOVIRINAE; ROUS SARCOMA VIRUS;

ADENOVIRIDAE; ANIMALS; ANTIVIRAL AGENTS; CELL SURVIVAL; FEMALE; GANCICLOVIR; GENE THERAPY; GENETIC VECTORS; HERPES SIMPLEX; HUMANS; IMMUNOBLOTTING; INJECTIONS, INTRAPERITONEAL; MELANOMA, EXPERIMENTAL; MESOTHELIOMA; MICE; MICE, INBRED BALB C; MICE, SCID; RATS; THYMIDINE KINASE; TIME FACTORS;

EID: 0033540353     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430349950018904     Document Type: Article

References (50)

1. AMALFITANO, A., HAUSER, M.A., HU, H., SERRA, D., BEGY, C.R., and CHAMBERLAIN, J.S. (1998). Production and characterization of improved adenovirus vectors with E1, E2b, and E3 genes deleted. J. Virol 72, 926-933.
2. ARMENTANO, D., SOOKDEO, C.C., HEHIR, K.M., GREGORY, R.J., ST. GEORGE, J.A., PRINCE, G.A., WADSWORTH, S.C., and SMITH, A.E. (1995). Characterization of an adenovirus gene transfer vector containing an E4 deletion. Hum. Gene Ther. 6, 1343-1353.
3. ARMENTANO, D., ZABNER, J., SACKS, C., SOOKDEO, C.C., SMITH, M.P., ST. GEORGE, J.A., WADSWORTH, S.C., SMITH, A.E., and GREGORY, R.J. (1997). Effect of the E4 region on the persistence of transgene expression from adenovirus vectors. J. Virol. 71, 2408-2416.
4. BERKNER, K.L. (1988). Development of adenovirus vectors for the expression of heterologous genes. BioTechniques 6, 616-629.
5. BOUCHER, R.C., KNOWLES, M.R., JOHNSON, L.G., OLSEN, J.C., PICKLES, R., WILSON, J.M., ENGELHARDT, J., YANG, Y., and GROSSMAN, M. (1994). Gene therapy for cystic fibrosis using E1-deleted adenovirus: A phase I trial in the nasal cavity. Hum. Gene Ther. 5, 615-639.
6. BRUDER, J.T., JIE, T., McVEY, D.L., and KOVESDI, I. (1997). Expression of gp19K increases the persistence of transgene expression from an adenovirus vector in the mouse lung and liver. J. Virol. 71, 7623-7628.
7. CRAIGHEAD, J.E., AKLEY, N.J., GOULD, L.B., and LIBBUS, B.G. (1987). Characteristics of tumors and tumor cells cultured from experimental asbestos-induced mesotheliomas in rats. Am. J. Pathol. 129, 448-462.
8. CRYSTAL, R. (1995). Transfer of genes to humans: Early lessons and obstacles to success. Science 270, 404-410.
9. DAI, Y., SCHWARTZ, H.M., GU, D., ZHANG, W.W., SARVETNICK, N., and VERMA, I.M. (1995). Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: Tolerization of factor IX and vector antigens allows for long term expression. Proc. Natl. Acad. Sci. U.S.A. 92, 1401-1405.
10. DAVIS, M.R., MANNING, L.S., WHITAKER, D., GARLEPP, M.J., and ROBINSON, B.W.S. (1992). Establishment of a murine model of malignant mesothelioma. Int. J. Cancer 52, 881-886.
11. DEDIEU, J., VIGNE, E., TORRENT, C., JULLIEN, C., MAHFOUZ, I., CAILLAUD, J., AUBAILLY, N., ORSINSI, C., GUILLAUME, J., OPOLON, P., DELAERE, P., PERRICAUDET, M., and YEH, P. (1997). Long-term gene delivery into the livers of immuncompetent mice with E1/E4-defective adenoviruses. J. Virol. 71, 4626-4637.
12. EASTHAM, J.A., CHEN, S.H., SEHGAL, I., YANG, G., TIMME, T.L., HALL, S.J., WOO, S.L., and THOMPSON, T.C. (1996). Prostate cancer gene therapy: Herpes simplex virus thymidine kinase gene transduction followed by ganciclovir in mouse and human prostate cancer models. Hum. Gene Ther. 7(4), 515-523.
13. EISENSMITH, R.C., and WOO, S.L. (1994). Gene therapy for phenylketonuria. Acta Paediatr. 407, 124-129.
14. EISENSMITH, R.C., and WOO, S.L. (1997). Viral vector-mediated gene therapy for hemophilia B. Thromb. Haemostasis 78(1):24-30.
15. ELSHAMI, A.A., KUCHARCZUK, J.C., ZHANG, H.B., SMYTHE, W.R., HWANG, H.C., LITZKY, L.A., KAISER, L.R., and ALBELDA, S.M. (1996). Treatment of pleural mesothelioma in an immunocompetent rat model utilizing adenoviral transfer of herpes simplex virus thymidine kinase gene. Hum. Gene Ther. 7, 141-148.
16. ELSHAMI, A.A., COOK, J.W., AMIN, K.M., CHOI, H., PARK, J.Y., COONROD, L., SUN, J., MOLNAR-KIMBER, K., WILSON, J.M., KAISER, L.R., and ALBELDA, S.M. (1997). The effect of promoter strength in adenoviral vectors containing herpes simplex virus thymidine kinase on cancer gene therapy in vitro and in vivo. Cancer Gene Ther. 4, 213-221.
17. ENGELHARDT, J.F., YANG, Y., STRATFORD-PERRICAUDET, L.D., ALLEN, E.D., KOZARSKY, K., PERRICAUDET, M., YANKASKAS, J.R., and WILSON, J.M. (1993). Direct gene transfer of human CFTR into human bronchial epithelia of xenografts with E1-deleted adenoviruses. Nature Genet. 4, 27-34.
18. ENGELHARDT, J.F., YE, X., DORANZ, B., and WILSON, J.M. (1994). Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc. Natl. Acad. Sci. U.S.A. 91, 6196-6200.
19. FALGOUT, B., and KETNER, G. (1988). Characterization of adenovirus particles made by deletion mutants lacking the fiber gene. J. Virol. 62, 622-625.
20. GAO, G.P., YANG, Y., and WILSON, J.M. (1996). Biology of adenovirus vectors with E1 and E4 deletions for liver-directed gene therapy. J. Virol. 70, 8934-8943.
21. GILGENKRANTZ, H., DUBOC, D., JULLIARD, V., COUTON, D., PAVIRANI, A., GUILLET, J.G., BRIAND, P., and KAHN, A. (1995). Transient expression of genes transferred in vivo into heart using first-generation adenoviral vectors: Role of immune response. Hum. Gene Ther. 6, 1265-1274.
22. GOODMAN, J.C., TASK, T.W., CHEN, S.H., WOO, S.L.C., GROSSMAN, R.G., CAREY, K.D., HUBBARD, G.B., CARRIER, D.A., RAJAGOPALAN, S., AGUILAR-CORDOVA, E., and SHINE, H.D. (1996). Adenoviral-mediated thymidine kinase gene transfer into the primate brain followed by systemic ganciclovir: Pathologic, radiologic, and molecular studies. Hum. Gene Ther. 7, 1241-1250.
23. HALBERT, D.N., CUTT, J.R., and SHENK, T. (1985). Adenovirus early region 4 encodes functions required for efficient DNA replication, late gene expression, and host cell shutoff. J. Virol. 56, 250-257.
24. HEHIR, K.M., ARMENTANO, D., CARDOZA, L.M., CHOQUETTE, T.L., BERTHELETTE, P.B., WHITE, G.A., COUTURE, A., EVERTON, M.B., KEEGAN, J., MARTIN, J.M., PRATT, D.A., SMITH, M.P., SMITH, A.E., and WADSWORTH, S.C. (1996). Molecular characterization of replication-competent variants of adenovirus vectors and genome modifications to prevent their occurrence. J. Virol. 70, 8459-8467.
25. JOOSS, K., ERTL, H.C., and WILSON, J.M. (1998). Cytotoxic T-lymphocyte target proteins and their major histocompatibility complex class I restriction in response to adenovirus vectors delivered to mouse liver. J. Virol. 72, 2945-2954.
26. KAPLAN, J.M., ARMENTANO, D., SPARER, T.E., WYNN, S.G., PETERSON, P.A., WADSWORTH, S.C., COUTURE, K.K., PENNTNGTON, S.E., ST. GEORGE, J.A., GOODING, L.R., and SMITH, A.E. (1997). Characterization of factors involved in modulating persistence of transgene expression from recombinant adenovirus in the mouse lung. Hum. Gene Ther. 8, 45-56.
27. 1-antitrypsin in mice after direct gene delivery in vivo. Hum. Gene Ther. 3, 641-647.
28. KUCHARCZUK, J.C., ELSHAMI, A.A., ZHANG, H.B., SMYTHE, W.R., HWANG, H.C., TOMLINSON, J.S., AMIN, K.M., LITZKY, L.A., ALBELDA, S.M., and KAISER, L.R. (1995). Pleural-based mesothelioma in immune competent rats: A model to study adenoviral gene transfer. Ann. Thorac. Surg. 60, 593-597.
29. KUCHARCZUK, J.C., RAPER, S., ELSHAMI, A.A., AMIN, K.M., STERMAN, D.H., WHEELDON, E.B., WILSON, J.M., LITZKY, L.A., KAISER, L.R., and ALBELDA, S.M. (1996). Safety of intrapleurally administered recombinant adenovirus carrying herpes simplex thymidine kinase DNA followed by ganciclovir therapy in nonhuman primates. Hum. Gene Ther. 7, 2225-2233.
30. KVIST, S., OSTBERG, L., PERSSON, H., PHILIPSON, L., and PETERSON, P.A. (1978). Molecular association between transplantation antigens and cell surface antigen in adenovirus-transformed cell line. Proc. Natl. Acad. Sci. U.S.A. 75, 5674-5678.
31. LUSKY, M., CHRIST, M., RITTNER, K., DIETERLE, A., DREYER, D., MOUROT, B., SCHULTZ, H., STOECKEL, F., PAVIRANI, A., and MEHTALI, M. (1998). In vitro and in vivo biology of recombinant adenovirus vectors and E1, E1/E2A, or E1/E4 deleted. J. Virol. 8, 45-56.
32. MEDGHALCHI, S., PADMANABHAN, R., and KETNER, G. (1997). Early region 4 modulates adenovirus DNA replication by two genetically separable mechanisms. Virology 236, 8-17.
33. O'MALLEY, B.W., CHEN, S.H., SCHWARTZ, M.R., and WOO, S.L. (1995). Adenovirus-mediated gene therapy for human head and neck squamous cell cancer in a nude model. Cancer Res. 55, 1080-1085.
34. PAABA, S., BHAT, B.M., WOLD, W.S., and PETERSON, P.A. (1987). A short sequence in the COOH-terminus makes an adenovirus membrane glycoprotein a resident of the endoplasmic reticulum. Cell 50, 311-317.
35. QUANTIN, B., PERRICAUDET, L.D., TAJBAKHSH, S., and MANDEL, J.L. (1992). Adenovirus as an expression vector in muscle in vivo. Proc. Natl. Acad. Sci. U.S.A. 89, 2581-2584.
36. ROSENFELD, M.E., WANG, M., SIEGAL, G.P., ALVAREZ, R.D., MIKHEEVA, G., KRASNYKH, V., and CURIEL, D.T. (1996). Adenoviral-mediated delivery of HSVtk results in tumor reduction and prolonged survival in a SCID mouse model of human ovarian carcinoma. J. Mol. Med. 74, 455-462.
37. SMYTHE, W.R., HWANG, H.C., AMIN, K.M., ECK, S.L., DAVIDSON, B.L., WILSON, J.M., KAISER, L.R., and ALBELDA, S.M. (1994a). Use of recombinant adenovirus to transfer the herpes simplex virus thymidine kinase (HSVtk) gene to thoracic neoplasms: An effective in vitro drug sensitization system. Cancer Res. 54(8), 2055-2059.
38. SMYTHE, W.R., KAISER, L.R., AMIN, K.A., PILEWSKI, J.M., ECK, S.J., WILSON, J.M., and ALBELDA, S.M. (1994b). Successful adenovirus-mediated gene transfer in an in vivo model of human malignant mesothelioma. Ann. Thor. Surg. 57, 1395-1401.
39. SMYTHE, W.R., HWANG, H.C., ELSHAMI, A.A., AMIN, K.M., ECK, S.L., DAVIDSON, B.L., WILSON, J.M., KAISER, L.R., and ALBELDA, S.M. (1995). Treatment of experimental human mesothelioma using adenovirus transfer of the herpes simplex thymidine kinase gene. Ann. Surg. 222, 78-86.
40. STERMAN, D.H., TREAT, J., LITSKY, L.A., AMIN, K.A., COONROD, L., MOLNAR-KIMBER, K., RECIO, A., KNOX, L., WILSON, J.M., ALBELDA, S.M., and KAISER, L.R. (1998). Adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir gene therapy in patients with localized malignancy: Result of a phase I clinical trial in malignant mesothelioma. Hum. Gene. Ther. 9, 1083-1092.
41. TOLLEFSON, A.E., HERMISTON, T.W., LICHTENSTEIN, D.L., COLLE, C.F., TRIPP, R.A., DIMITROV, T., TOTH, K., WELLS, C.E., DOHERTY, P.C., and WOLD, W.S.M. (1998). Forced degradation of Fas inhibits apoptosis in adenovirus-infected cells. Nature (London) 392, 726-730.
42. WANG, Q., and FINER, M.H. (1996). Second generation adenovirus vectors. Nature Med. 2, 714-716.
43. WANG, Q., JIA, X.-C., and FINER, M.H. (1995). A packaging cell line for propagation of recombinant adenovirus vectors containing two lethal gene-region deletions. Gene Ther. 2, 775-783.
44. WANG, Q., GREENBURG, C., BUNCH, D., PARSON, D., and FINER, M.H. (1997). Persistent transgene expression in mouse liver following in vivo gene transfer with E1/E4-deleted adenovirus vectors. Gene Ther. 4, 393-400.
45. WILSON, J.M. (1993). Vehicles for gene therapy. Nature (London) 365, 691.
46. YANG, Y., and WILSON, J.A. (1995). Clearance of adenovirus-infected hepatocytes by MHC class I-restricted CD4+ CTLs in vivo. J. Immunol. 155, 2564-2570.
47. YANG, Y., NUNES, F.A., BERENCSI, K., FURTH, E.E., GONCZOL, E., and WILSON, J.M. (1994). Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. U.S.A. 91, 4407-4411.
48. YANG, Y., HAECKER, S.E., SU, Q., and WILSON, J.M. (1996). Immunology of gene therapy with adenoviral vectors in mouse skeletal muscle. Hum. Mol. Genet. 5, 1703-1712.
49. ZABNER, J., COUTURE, L.A., GREGORY, R.J., GRAHAM, S.M., SMITH, A.E., and WELSH, M.J. (1993). Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis. Cell 75, 207-216.
50. ZSIGMOND, E., KOBAYASHI, K., TZUNG, K.W., LI, L., FUKE, Y., and CHANG, L. (1997). Adenovirus-mediated gene transfer of human lipoprotein lipase amelioriates the hyperlipidemias associated with apolipoprotein E and LDL receptor deficiencies in mice. Hum. Gene Ther. 8(16), 1921-1933.